GB0301916D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0301916D0
GB0301916D0 GB0301916A GB0301916A GB0301916D0 GB 0301916 D0 GB0301916 D0 GB 0301916D0 GB 0301916 A GB0301916 A GB 0301916A GB 0301916 A GB0301916 A GB 0301916A GB 0301916 D0 GB0301916 D0 GB 0301916D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0301916A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0301916A priority Critical patent/GB0301916D0/en
Publication of GB0301916D0 publication Critical patent/GB0301916D0/en
Priority to TW092106024A priority patent/TWI324597B/en
Priority to TW096130334A priority patent/TW200813014A/en
Priority to NZ535014A priority patent/NZ535014A/en
Priority to SI200331852T priority patent/SI1487806T1/en
Priority to US10/508,675 priority patent/US20050215574A1/en
Priority to PL372889A priority patent/PL214880B1/en
Priority to BR0308670-4A priority patent/BR0308670A/en
Priority to MYPI20031118A priority patent/MY158054A/en
Priority to CA2479642A priority patent/CA2479642C/en
Priority to AT03710015T priority patent/ATE473215T1/en
Priority to DE60333262T priority patent/DE60333262D1/en
Priority to KR1020047015473A priority patent/KR101006947B1/en
Priority to IL16413503A priority patent/IL164135A0/en
Priority to EP03710015A priority patent/EP1487806B1/en
Priority to AU2003214443A priority patent/AU2003214443B8/en
Priority to DK03710015.3T priority patent/DK1487806T3/en
Priority to MXPA04009486A priority patent/MXPA04009486A/en
Priority to PCT/GB2003/001306 priority patent/WO2003082831A1/en
Priority to ES03710015T priority patent/ES2346135T3/en
Priority to JP2003580299A priority patent/JP3891493B2/en
Priority to UA20041008762A priority patent/UA78302C2/en
Priority to CNB038117398A priority patent/CN100439344C/en
Priority to PT03710015T priority patent/PT1487806E/en
Priority to UY27742A priority patent/UY27742A1/en
Priority to ARP030101122A priority patent/AR039203A1/en
Priority to SA03240080A priority patent/SA03240080B1/en
Priority to IL164135A priority patent/IL164135A/en
Priority to IS7469A priority patent/IS2855B/en
Priority to NO20044325A priority patent/NO329542B1/en
Priority to HK05103509.3A priority patent/HK1070888A1/en
Priority to HK05111553.1A priority patent/HK1079521A1/en
Priority to JP2006102765A priority patent/JP2006249093A/en
Priority to US12/147,250 priority patent/US20080269487A1/en
Priority to US12/706,675 priority patent/US8399667B2/en
Priority to CY20101100824T priority patent/CY1111039T1/en
Priority to US13/608,092 priority patent/US20130005727A1/en
Ceased legal-status Critical Current

Links

GB0301916A 2002-03-28 2003-01-28 Compounds Ceased GB0301916D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GB0301916A GB0301916D0 (en) 2003-01-28 2003-01-28 Compounds
TW092106024A TWI324597B (en) 2002-03-28 2003-03-19 Quinazoline derivatives
TW096130334A TW200813014A (en) 2002-03-28 2003-03-19 Quinazoline derivatives
PT03710015T PT1487806E (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PCT/GB2003/001306 WO2003082831A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
JP2003580299A JP3891493B2 (en) 2002-03-28 2003-03-26 4-anilinoquinazoline derivatives as antitumor agents
US10/508,675 US20050215574A1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
PL372889A PL214880B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
BR0308670-4A BR0308670A (en) 2002-03-28 2003-03-26 Quinazoline derivative or a pharmaceutically acceptable salt thereof, process for preparing it, pharmaceutical composition, use of said derivative or salt thereof, method for producing an antiproliferative effect on a warm-blooded animal in need of such treatment, and , compound or a salt thereof.
MYPI20031118A MY158054A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
CA2479642A CA2479642C (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
AT03710015T ATE473215T1 (en) 2002-03-28 2003-03-26 4-ANILINEQUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE ACTIVE INGREDIENTS
DE60333262T DE60333262D1 (en) 2002-03-28 2003-03-26 4-anilinchinazolinderivate als antiproliferative wirkstoffe
KR1020047015473A KR101006947B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
IL16413503A IL164135A0 (en) 2002-03-28 2003-03-26 4-Anilino quinazoline derivatives as antirpoliferative agents
EP03710015A EP1487806B1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
AU2003214443A AU2003214443B8 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
DK03710015.3T DK1487806T3 (en) 2002-03-28 2003-03-26 4-aniline quinazoline derivatives as antiproliferative agents
MXPA04009486A MXPA04009486A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents.
NZ535014A NZ535014A (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
ES03710015T ES2346135T3 (en) 2002-03-28 2003-03-26 DERIVATIVES OF 4-ANILINO QUINAZOLINA AS ANTIPROLIFERATIVE AGENTS.
SI200331852T SI1487806T1 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
UA20041008762A UA78302C2 (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
CNB038117398A CN100439344C (en) 2002-03-28 2003-03-26 4-anilino quinazoline derivatives as antiproliferative agents
UY27742A UY27742A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
ARP030101122A AR039203A1 (en) 2002-03-28 2003-03-28 QUINAZOLINE DERIVATIVES
SA03240080A SA03240080B1 (en) 2002-03-28 2003-04-16 4-ANILINO QUINAZOLINE derivatives AS ANTIPROLIFERATIVES AGENTS
IL164135A IL164135A (en) 2002-03-28 2004-09-19 4-anilino quinazoline derivatives as antiproliferative agents, process for their preparation, pharmaceutical compositions containing such derivatives and use thereof for the preparation of medicaments for the treatment of cancer
IS7469A IS2855B (en) 2002-03-28 2004-09-24 4-anilinoquinazoline derivatives as a propagating agent
NO20044325A NO329542B1 (en) 2002-03-28 2004-10-12 4-Anilinoquinazoline Derivatives, Methods for Preparing Such, Pharmaceutical Preparations Containing Such, Such Compounds for Use as a Medication, and Use of Such Compounds for the Preparation of Medication for the Treatment of Disease
HK05103509.3A HK1070888A1 (en) 2002-03-28 2005-04-25 4-anilino quinazoline derivatives as antiproliferative agents
HK05111553.1A HK1079521A1 (en) 2002-03-28 2005-12-15 4-anilino quinazoline derivatives as antiproliferative agents
JP2006102765A JP2006249093A (en) 2002-03-28 2006-04-04 4-anilinoquinazoline derivative as antineoplastic agent
US12/147,250 US20080269487A1 (en) 2002-03-28 2008-06-26 4-anilino quinazoline derivatives as antiproliferative agents
US12/706,675 US8399667B2 (en) 2002-03-28 2010-02-16 4-anilino quinazoline derivatives as antiproliferative agents
CY20101100824T CY1111039T1 (en) 2002-03-28 2010-09-09 4-ANILINO KINAZOLIN DERIVATIVE AS ANTI-COLLAPABLE FACTORS
US13/608,092 US20130005727A1 (en) 2002-03-28 2012-09-10 Quinazoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0301916A GB0301916D0 (en) 2003-01-28 2003-01-28 Compounds

Publications (1)

Publication Number Publication Date
GB0301916D0 true GB0301916D0 (en) 2003-02-26

Family

ID=9951939

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0301916A Ceased GB0301916D0 (en) 2002-03-28 2003-01-28 Compounds

Country Status (1)

Country Link
GB (1) GB0301916D0 (en)

Similar Documents

Publication Publication Date Title
GB0309781D0 (en) Compounds
GB0316915D0 (en) Compounds
GB0315950D0 (en) Compounds
GB0305559D0 (en) Compounds
GB0317268D0 (en) Compounds
GB0314476D0 (en) Compounds
GB0314479D0 (en) Compounds
GB0314478D0 (en) Compounds
EP1689403A4 (en) Heteroaryl-hydrazone compounds
GB0304665D0 (en) Compounds
GB0305553D0 (en) Compounds
GB0313915D0 (en) Compounds
GB0306329D0 (en) Compounds
GB0313914D0 (en) Compounds
EP1658301A4 (en) N-desmethyl-n-substituted-11-deoxyerythromycin compounds
EP1682514A4 (en) 11- o-methylgeldanamycin compounds
GB0304494D0 (en) Compounds
GB0302512D0 (en) Compounds
GB0317269D0 (en) Compounds
GB0308105D0 (en) Compounds
GB0311688D0 (en) Compounds
GB0307998D0 (en) Compounds
GB0308017D0 (en) Compounds
GB0301916D0 (en) Compounds
GB0309326D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)